{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-26-000007","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.909081+00:00","generated_at":"2026-05-16T00:45:03.793824+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Supernus raises CEO salary to $1.067M, awards $847K bonus and equity grants","bullets":["CEO salary increased to $1,067,100 from $1,036,000; 2025 bonus $846,930.","CEO granted options for 341,610 shares and 204,966 PSUs at $50.20 strike.","CFO salary raised to $525,100 from $504,900; 2025 bonus $233,894.","CFO gets 17,500 options, 3,000 RSUs, and 3,500 PSUs.","Three other execs (Bhatt, Rubin, Mottola) also received salary increases and equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-26-000007","json":"https://secwatch.observer/filing/0001356576-26-000007.json","markdown":"https://secwatch.observer/filing/0001356576-26-000007.md","text":"https://secwatch.observer/filing/0001356576-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657626000007/0001356576-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657626000007/supn-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:45:03.793824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}